Clinical Trial Update: "Embolization Before Ablation of Renal Cell Carcinoma (EMBARC)" [NA]

View source ↗

Summary

The EMBARC trial assessing embolization before ablation for renal cell carcinoma (RCC) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Renal Cell Carcinoma (RCC) | NA | Status: COMPLETED